¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"plasma cross matching"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • plasma membrane
    ÇüÁú¸·
  • plasma pepsinogen
    Ç÷ÀåÆé½Ã³ë°Õ
  • plasma substitute
    Ç÷Àå´ëüÁ¦
  • plasma thromboplastin factor
    Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ
  • plasma volume expander
    Ç÷ÀåÁõ·®Á¦
  • pooled blood plasma
    È¥ÇÕÇ÷Àå
  • seminal plasma
    Á¤¾×Àå¾×
  • blue cross
    û½ÊÀÚ
  • criss-cross inheritance
    ½ÊÀÚÀ¯Àü, À̼ºÀ¯Àü
  • cross
    ±³Â÷
  • cross absorption
    ±³Â÷Èí¼ö
  • cross birth
    ȾÀ§ºÐ¸¸
  • cross bridge
    ±³Â÷°áÇÕ, ¿¬°á´Ù¸®
  • cross bridge cycle
    ±³Â÷°áÇÕÁÖ±â
  • cross circulation
    ±³Â÷¼øÈ¯
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • plasma iron disappearance rate
    Ç÷Àåö¼Ò½Ç·ü
  • plasma iron turnover rate
    Ç÷Àåö±³Ã¼À²
  • pooled blood plasma
    È¥ÁÖÇ÷Àå
  • seminal plasma
    Á¤¾×Àå¾×
  • true plasma
    ¼øÇ÷Àå
  • stable plasma protein solution
    ¾ÈÁ¤Ç÷Àå´Ü¹é¿ë¾×
  • cross absorption
    ±³Â÷Èí¼ö
  • cross-modal association
    ±³Â÷½Ä¿¬ÇÕ
  • cross-reacting antibody
    ±³Â÷¹ÝÀÀÇ×ü
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀÇ׿ø
  • blue cross
    û½ÊÀÚ
  • cross birth
    ³­»ê, ȾÀ§ºÐ¸¸
  • cross bridge
    ±³Â÷°áÇÕ, ¿¬°á´Ù¸®
  • cross
    ±³Â÷
  • cross-antigenicity
    ±³Â÷Ç׿ø¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • plasma cell
    ÇüÁú¼¼Æ÷
  • plasma cell dyscrasia
    ÇüÁú¼¼Æ÷ÀÌȥȭÁõ
  • plasma cell dyscrasia
    ÇüÁú¼¼Æ÷Áúȯ(û¡òõá¬øàòðü´), ÇüÁú¼¼Æ÷Àå¾Ö(¡­î¡äô), ÇüÁú¼¼Æ÷ÀÌȥȭÁõ(¡­ì¶ûèûúñø)
  • plasma cell gingivostomatitis
    ÇüÁú¼¼Æ÷ Ä¡Àº ±¸³»¿°
  • plasma cell leukemia
    ÇüÁú¼¼Æ÷¼º ¹éÇ÷º´
  • plasma cell leukemia
    ÇüÁú¼¼Æ÷¼º ¹éÇ÷º´(û¡òõá¬øààõ ÛÜúìÜ»)
  • plasma cell leukemia
    ÇüÁú¼¼Æ÷ ¹éÇ÷º´
  • plasma cell mastitis
    ÇüÁú¼¼Æ÷¼ºÀ¯¹æ¿°(û¡òõá¬øààõêáÛ®æú)
  • plasma cell myeloma
    ÇüÁú¼¼Æ÷ °ñ¼öÁ¾
  • plasma cell myeloma
    ÇüÁú¼¼Æ÷°ñ¼öÁ¾(û¡òõá¬øàÍéâÐðþ)
  • plasma cell pneumonia
    ÇüÁú¼¼Æ÷¼º Æó·Å.
  • plasma cell pneumonia
    ÇüÁú¼¼Æ÷¼ºÆó·Å(û¡òõá¬øààõøËæú)
  • plasma cell tumor
    ÇüÁú¼¼Æ÷Á¾¾ç
  • plasma cell vulvitis
    ÇüÁú¼¼Æ÷ ¿©¼ºÀ½ºÎ¿°
  • plasma clot
    Ç÷À屫.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cross finger flap
    ±³Â÷ÁöÇÇºÎÆÇ(Îßó©ò¦ù«Ý±÷û).
  • cross fire irradiation
    ½ÊÀÚÆ÷È­Á¶»ç
  • cross fire technique
    ½ÊÀÚÆ÷È­Á¶»ç¹ý
  • cross fixation
    ±³Â÷ÁÖ½Ã
  • cross foot
    ³»¹ø Á·(Ò®Ûèðë).
  • cross hair
    ½ÊÀÚ¼±
  • cross hatching incision
    ±³Â÷Àý°³
  • cross heredity
    ±³Â÷(¼º)À¯Àü(Îßó©àõë¶îî).
  • cross immunity
    ±³Â÷¸é¿ª(¡­Øóæ¹).
  • cross incision
    ½ÊÀÚÀý°³(½ÊÀÚü°³).
  • cross infection
    ±³Â÷°¨¿°(Îßó©Êïæø).
  • cross inheritance
    ±³Â÷À¯Àü(Îßó©ë¶îî).
  • cross leg flap
    ÇÏÅð±³Â÷ÇÇÆÇ.
  • cross link
    ±³Â÷°áÇÕ, Ⱦ°áÇÕ.
  • cross linking
    ±³Â÷°áÇÕ(Îßó©Ì¿ùê).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cross-electrophoresis
    ±³Â÷Àü±â¿µµ¿(Îßó©ï³Ñ¨ç¶ÔÑ)
  • cross-hybridization
    ±³Â÷(Îßó©)Æ¢±â Çü¼º(û¡à÷)
  • cross-induction
    ±³Â÷À¯µµ(Îßó©ë¯Óô)
  • cross-infection
    ±³Â÷°¨¿°(Îßó©Êïæø)
  • cross-linker
    ±³Â÷¿¬°èÀÚ(Îßó©ææÍ¨í­)
  • cross-linking
    ±³Â÷¿¬°è(Îßó©ææÍ¨)
  • cross-partition
    ±³Â÷ºÐ¹è(Îßó©ÝÂÛÕ)
  • cross-reacting antibody
    ±³Â÷¹ÝÀÀ Ç×ü(Îßó©Úãëëù÷ô÷)
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀ Ç׿ø(Îßó©Úãëëù÷ê«)
  • cross-reacting material
    ±³Â÷¹ÝÀÀ ¹°Áú(Îßó©ÚãëëÚªòõ)
  • cross-reaction
    ±³Â÷¹ÝÀÀ(Îßó©Úãëë)
  • cross-reactivation
    ±³Â÷ÀçȰ¼ºÈ­(Îßó©î¢üÀàõûù)
  • cross-resistance
    ±³Â÷ÀúÇ×(Îßó©î½ù÷)
  • cross-sensitization
    ±³Â÷°¨ÀÛ(Îßó©ÊïíÂ)
  • cross-term diffusion coefficient
    ¹æÇØ È®»ê°è¼ö(Ûªúªüªß¤Íªâ¦)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PG paregoric; parotid gland; pentagastrin; pepsinogen; peptidoglycan; Pharmacopoeia Germanica; phosphat...
PP diphosphate group; emphysema [pink puffers]; near point of accommodation [Lat. punctum proximum]; pa...
PV pancreatic vein; papillomavirus; paraventricular; paravertebral; pemphigus vulgaris; peripheral vasc...
CREG Cross REactive Group (of HLA Antigens)
IRC International Red Cross
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BCF Beat cross frequency
CP-MAS Cross Polarisation Magic Angle Spinning
CRD Cross Reacting Determinant
CSA Cross sectional areas
CCF Cross-correlation functions
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cross bite occlusion
    ±³Â÷ ±³ÇÕ
  • cross contamination
    ±³Â÷ ¿À¿°
  • cross fire technique
    ½ÊÀÚÆ÷È­ Á¶»ç¹ý
  • cross heredity
    ±³Â÷ À¯Àü, ±³Â÷¼º À¯Àü
  • cross incision
    ½ÊÀÚ Àý°³
  • cross leg flap
    ÇÏÅð ±³Â÷ ÇÇÆÇ
  • cross linkage
    °¡±³È­
  • cross linking agent
    °¡±³Á¦
    ¼±»ó °íºÐÀÚÀÇ ºÐÀÚ°£À» È­ÇÐÀûÀ¸·Î °áÇÕÇϰí, ±×¹° ±¸Á¶¸¦ ¸¸µå´Â ÀÛ¿ëÀ» °®´Â ¹°Áú.
  • cross polymerization
    ±³Â÷ ÁßÇÕ
    ¼±»ó ÁßÇÕü ºÐÀÚ »çÀÌÀÇ È­ÇÐ °áÇÕ Çü¼ºÀº ±× ºÐÀÚµé·Î½á µÈ ¹«ÇÑ´ëÀÇ »ïÂ÷¿øÀû ¸Á»ó ±¸Á¶¿¡±îÁö À̸¦ ¼ö ÀÖ´Â ÁßÇÕ ¹ÝÀÀÀÌ´Ù. ±×·¡¼­ Àç·áÀÇ ¿ëÇØµµ, °­µµ, Èí¼ö¼ºÀ» ¹Ù²Ù´Â ÀÔüÀûÀÎ ¸Á»ó ±¸Á¶¸¦ Çü¼ºÇÏ°Ô µÈ´Ù.
  • cross reaction
    ±³Â÷ ¹ÝÀÀ
    Ç׿ø Ç×ü ¹ÝÀÀÀÇ °¡Àå Å« Ư¡Àº ÀÌ ¹ÝÀÀÀÌ Æ¯ÀÌÀûÀ̶ó´Â °ÍÀε¥ ¶§·Î´Â ÀÌ ¿øÄ¢¿¡ ¸ÂÁö ¾Ê´Â ¹ÝÀÀÀ» º¸ÀÌ°Ô µÇ´Â ¼ö°¡ ÀÖ´Ù. ¿¹¸¦ µé¾î ¼ÒÀÇ Ç÷û ¾ËºÎ¹Î¿¡ ´ëÇÑ Ç×ü´Â ¾çÀÇ Ç÷û ¾ËºÎ¹Î°úµµ ¾î´À Á¤µµ ¹ÝÀÀÇϴµ¥ ÀÌ °°Àº ¹ÝÀÀÀ» ±³Â÷ ¹ÝÀÀÀ̶ó ÇÑ´Ù.
  • cross relaxation
    ±³Â÷ ÀÌ¿Ï
  • cross section radiography
    Ⱦ´Ü ¹æ»ç¼± ÃÔ¿µ¼ú
  • cross sensitivity
    ±³Â÷ °ú¹Î ¹ÝÀÀ
  • cross striation
    °¡·Î¹«´Ì, Ⱦ¹®
  • cross tolerance
    ±³Â÷ ³»¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
cross-resistance <immunology, microbiology> Immunologic resistance to the pathogenic effects of a microorganism because of previous exposure to another species or type having cross reactive antigens.
This phenomenon is seen in microbes that acquire resistance to one drug through direct exposure and turn out to have resistance to one or more other drugs to which it has not been exposed. Cross-resistance arises because the mechanism of resistance to several drugs is the same and arises through the identical genetic mutations.
(09 Oct 1997)
cross-section <physics> Usually refers to the (apparent) area presented by a target particle to an oncoming particle (or electromagnetic wave). This measures the probability of an interaction occuring. For typical interactions between ions and electrons, or between two nuclei, these cross sections are generally measured in barns.
<anatomy> A transverse cut through a structure or tissue. The opposite of a cross-section is a longitudinal section. By analogy, a study may be cross-sectional or longitudinal.
(12 Dec 1998)
cross-sectional echocardiography two-dimensional echocardiography
cross-sectional method <epidemiology> The study of the life span involving comparison of groups of individuals at different age levels.
Compare: longitudinal method.
(05 Mar 2000)
cross-sectional study <epidemiology> A study in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with longitudinal studies which are followed over a period of time.
Synonym: horizontal study.
(18 Jul 2002)
cross-table lateral projection <radiology> Lateral projection radiography of a supine subject using a horizontal X-ray beam.
(05 Mar 2000)
cross tolerance <pharmacology> The resistance to one or several effects of a compound as a result of tolerance developed to a pharmacologically similar compound.
(05 Mar 2000)
section, cross A transverse cut through a structure. The opposite is a longitudinal section.
(12 Dec 1998)
holy cross The cross as the symbol of Christ's crucifixion. Congregation of the Holy Cross, a community of lay brothers and priests, in France and the United States, engaged chiefly in teaching and manual Labour. Originally called Brethren of St. Joseph. The Sisters of the Holy Cross engage in similar work. Holy-cross day, the fourteenth of September, observed as a church festival, in memory of the exaltation of our Savior's cross.
Source: Websters Dictionary
(01 Mar 1998)
study, cross-sectional A study done at one time, not over the course of time. A cross-sectional study a disease such as aids might be designed to learn its prevalence and distribution within the population at one point in time. Also known as a synchronic study.
(12 Dec 1998)
double back cross A mating that is a back cross at each of two loci of interest; of special value and importance in linkage analysis.
(05 Mar 2000)
International Committee of the Red Cross A neutral Swiss organization serving as an intermediary between contending forces in armed conflict, in civil war, or internal strife, to help victims receive protection and other humanitarian assistance under the Geneva Conventions in accordance with the fundamental principles of the Red Cross.
(05 Mar 2000)
test cross Crossing of an unknown genotype to a recessive homozygote so that the phenotype of the progeny corresponds directly to the chromosomes carried by the parents of unknown genotype.
In experimental genetics, a deliberate mating designed to test claims about the pattern of inheritance of one or more traits.
Synonym: backcross.
(05 Mar 2000)
League of Red Cross Societies The international federation of national Red Cross and similar societies.
(05 Mar 2000)
antihemophilic plasma Human plasma in which the labile antihemophilic globulin component, present in fresh plasma, has been preserved; it is used to temporarily relieve dysfunction of the haemostatic mechanism in haemophilia.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cross
    (2¼±ÀÌ)±³Â÷ÇÏ´Ù;(±æ.°­À»)°Ç³Ê°¡´Ù;(...¿¡¼­...À¸·Î)°Ç³Ê´Ù;µµÇ×ÇÏ´Ù;(µÎ »ç¶÷ÀÌ)½ºÃÄÁö³ª°¡´Ù;(µÎÀåÀÇ ÆíÁö µîÀÌ)¾ù°¥¸®´Ù;(µ¿½Ä¹°ÀÌ)±³¹èÇÏ´Ù;ÀâÁ¾ÀÌ µÇ´Ù;±³Â÷ÇÑ;°¡·ÎÀÇ;ºñ½ºµëÇÑ;°¡·ÎÁö¸¥;...¿Í ¾ù°¥¸°;...¿¡ ¹Ý´ëµÇ´Â;¹è¹ÝÇÏ´Â;¹Ý´ëÀÇ;°Å²Ù·ÎÀÇ;¿ªÀÇ;ºÒ¸®ÇÑ;ºÒÆíÇÑ;½Ã
  • cross
    ½ÊÀÚÇü;½ÊÀÚ°¡;±×¸®½ºµµ°¡ ¸ø¹ÚÈù ½ÊÀÚ°¡;±×¸®½ºµµÀÇ ¼ö³­;¼ÓÁË;±×¸®½ºµµÀÇ ¼ö³­»ó(µµ);(½ÊÀÚ°¡·Î »ó¡µÇ´Â)±âµ¶±³(±¹°¡)(Christianity,Christendo m);¼ö³­;½Ã·Ã;°í³­(affliction);°í»ý(°Å¸®);ºÒÇà;Àå¾Ö;½ÊÀÚ²Ã;½ÊÀÚ ±âÈ£;xÇ¥(¹®¸ÍÀÚÀÇ ¼­¸íÀÇ ´ë¿ë);(¸Í¼¼.ÃູµîÀ» ÇÒ¶§ °ø
  • cross
    ÀâÁ¾(mongrel);ÀýÃæ;Áß°£¹°;ºÎÁ¤;±â¸¸;¾ß¹ÙÀ§;(½ÊÀÚÇüÀÇ Á¾·ù);±³Â÷½ÃŰ´Ù;¾ù°É´Ù;(¼­·Î)±³Â÷ÇÏ´Ù;½ÊÀÚ(¼ºÈ£)¸¦ ±ß´Ù;°¡·ÎÁÙÀ» ±ß´Ù;(¼öÇ¥¿¡)Ⱦ¼±À» ±ß´Ù;¸»»ìÇÏ´Ù;(¾´ ÆíÁö À§¿¡)´Ù½Ã ±³Â÷ÀûÀ¸·Î ½á³Ö´Ù(¿ìÆí ¿ä±ÝÀ» ¾Æ³¢±â À§ÇÏ¿©);(±æ.»ç¸· µîÀ»)°¡·ÎÁö¸£´Ù;Ⱦ´ÜÇÏ´Ù;³Ñ´Ù
  • cross action
    ¹Ý´ë ¼Ò¼Û;¹Ý¼Ò
  • cross bun
    ½ÊÀÚ ¹«´Ì·Î ´çÀǸ¦ ÀÔÈù °úÀÚ »§
  • cross counter
    Å©·Î½ºÄ«¿îÅÍ(»ó´ë¹æ °ø°Ý¿¡ ´ëÇØ ±³Â÷ÀûÀ¸·Î °¡ÇÏ´Â ¹Ý°Ý)
  • cross current
    ¿ª·ù;´ë¸³ÇÏ´Â °æÇâ
  • cross cut
    °¡·Î ÄÑ´Â (Åé);°¡·Î ÀÚ¸¥;»û±æ;Áö¸§±æ;(Àç¸ñÀÇ)°¡·ÎÄѱâ;ȰÁÖÇüÀÇ ÀÏÁ¾(½ºÄÉÀÌÆ®);°¡·ÎÄÑ´Ù;°¡·ÎÁö¸£´Ù;~ter
  • cross fire
    ½ÊÀÚÆ÷È­;(Áú¹®ÀÇ)ÀÏÁ¦ °ø¼¼;(¸»ÀÇ)°Ý·ÄÇÑ ÀÀ¼ö;Ç÷¹ÀÌÆ®ÀÇ °¢À» ÁÇ·Î °¡·ÎÁö¸£´Â Åõ±¸
  • cross grain
    ¾ù°á
  • cross hairs
    (¸Á¿ø°æ µîÀÇ ÃÐÁ¡¿¡ »ý±ä)½ÊÀÚ¼±
  • cross keys
    2 °³ÀÇ ¿­¼è°¡ ±³Â÷ÇÑ ¹®Àå(·Î¸¶ ±³È²ÀÇ)
  • cross license
    »óÈ£ ƯÇã »ç¿ë Çã°¡
  • cross multiply
    µÎ ºÐ¼öÀÇ °¢°¢ÀÇ ºÐÀÚ¿¡ ´Ù¸¥ ºÐ¼öÀÇ ºÐ¸ð¸¦ °öÇÏ´Ù
  • cross rate
    Å©·Î½º ·¹ÀÌÆ®;¿µ.¹Ì ȯ½Ã¼¼
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á